Ovarian Cancer Trial, Recruiting (NCT01558544)

Ovarian Cancer Trial, Recruiting NCT01558544 Sponsor: Weill Medical College of Cornell University Condition: Ovarian Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT01558544 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Ovarian Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Female patients aged 0 to 45 years who have not yet gone through menopause
Patients who have a planned medical treatment that is likely to cause early menopause or early loss of ovarian function, such as radiation to the abdomen or pelvis, high-dose chemotherapy, or surgery to remove the ovaries (for example, in patients with a BRCA gene mutation)
Patients who are not able or do not wish to preserve fertility through egg or embryo freezing
Patients who have previously had cancer treatment may still be considered, as long as the ovaries are still working
Patients who are healthy enough to have surgery and have been cleared for anaesthesia

Who may not be able to join:

Patients who do not meet the criteria listed above
Patients who have not been given medical clearance by their doctors to undergo surgery
Patients who have already gone through menopause

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 12 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Glenn Schattman, MD, Weill Medical College of Cornell University

Phone: 646-962-3276

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT01558544

Sponsor: Weill Medical College of Cornell University

Phase: Not Applicable

Status: Recruiting

Condition: Ovarian Cancer

Trial contact: 646-962-3276

More information: https://clinicaltrials.gov/study/NCT01558544

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Female patients aged 0 to 45 years who have not yet gone through menopause
Patients who have a planned medical treatment that is likely to cause early menopause or early loss of ovarian function, such as radiation to the abdomen or pelvis, high-dose chemotherapy, or surgery to remove the ovaries (for example, in patients with a BRCA gene mutation)
Patients who are not able or do not wish to preserve fertility through egg or embryo freezing
Patients who have previously had cancer treatment may still be considered, as long as the ovaries are still working
Patients who are healthy enough to have surgery and have been cleared for anaesthesia

Who may not be able to join:

Patients who do not meet the criteria listed above
Patients who have not been given medical clearance by their doctors to undergo surgery
Patients who have already gone through menopause

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 12 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Weill Medical College of Cornell University

Registry

ClinicalTrials.gov

Start date

1 April 1997

Est. completion

31 October 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

CRYOPRESERVATION OF OVARIAN TISSUE FOR POTENTIAL IN VITRO MATURATION OR AUTOLOGOUS TRANSPLANTATION

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov